These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26781748)

  • 1. Multi-omic measurement of mutually exclusive loss-of-function enriches for candidate synthetic lethal gene pairs.
    Wappett M; Dulak A; Yang ZR; Al-Watban A; Bradford JR; Dry JR
    BMC Genomics; 2016 Jan; 17():65. PubMed ID: 26781748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated genomic and pharmacological approaches to identify synthetic lethal genes as cancer therapeutic targets.
    Mizuarai S; Irie H; Schmatz DM; Kotani H
    Curr Mol Med; 2008 Dec; 8(8):774-83. PubMed ID: 19075675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DiscoverSL: an R package for multi-omic data driven prediction of synthetic lethality in cancers.
    Das S; Deng X; Camphausen K; Shankavaram U
    Bioinformatics; 2019 Feb; 35(4):701-702. PubMed ID: 30059974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
    Srihari S; Singla J; Wong L; Ragan MA
    Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using pooled miR30-shRNA library for cancer lethal and synthetic lethal screens.
    Lee LC; Gao S; Li Q; Luo J
    Methods Mol Biol; 2014; 1176():45-58. PubMed ID: 25030918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancy of Cancers and Synthetic Lethal Interactions Associated With Mutations of Cancer Driver Genes.
    Wang X; Zhang Y; Han ZG; He KY
    Medicine (Baltimore); 2016 Feb; 95(8):e2697. PubMed ID: 26937901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential synthetic lethal genes to p53 using a computational biology approach.
    Wang X; Simon R
    BMC Med Genomics; 2013 Sep; 6():30. PubMed ID: 24025726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic lethal interactions for the development of cancer therapeutics: biological and methodological advancements.
    Mizuarai S; Kotani H
    Hum Genet; 2010 Dec; 128(6):567-75. PubMed ID: 20976469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranking novel cancer driving synthetic lethal gene pairs using TCGA data.
    Ye H; Zhang X; Chen Y; Liu Q; Wei J
    Oncotarget; 2016 Aug; 7(34):55352-55367. PubMed ID: 27438146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of large-scale loss-of-function screens identifies robust cancer-associated genetic interactions.
    Lord CJ; Quinn N; Ryan CJ
    Elife; 2020 May; 9():. PubMed ID: 32463358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genome.
    Parrish PCR; Thomas JD; Gabel AM; Kamlapurkar S; Bradley RK; Berger AH
    Cell Rep; 2021 Aug; 36(9):109597. PubMed ID: 34469736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming selection bias in synthetic lethality prediction.
    Seale C; Tepeli Y; Gonçalves JP
    Bioinformatics; 2022 Sep; 38(18):4360-4368. PubMed ID: 35876858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic lethal genetic screens in Ras mutant cancers.
    Yu B; Luo J
    Enzymes; 2013; 34 Pt. B():201-19. PubMed ID: 25034106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancer.
    Geng H; Qian R; Zhong Y; Tang X; Zhang X; Zhang L; Yang C; Li T; Dong Z; Wang C; Zhang Z; Zhu C
    Cancer Gene Ther; 2024 Feb; 31(2):334-348. PubMed ID: 38040871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening.
    McDonald ER; de Weck A; Schlabach MR; Billy E; Mavrakis KJ; Hoffman GR; Belur D; Castelletti D; Frias E; Gampa K; Golji J; Kao I; Li L; Megel P; Perkins TA; Ramadan N; Ruddy DA; Silver SJ; Sovath S; Stump M; Weber O; Widmer R; Yu J; Yu K; Yue Y; Abramowski D; Ackley E; Barrett R; Berger J; Bernard JL; Billig R; Brachmann SM; Buxton F; Caothien R; Caushi JX; Chung FS; Cortés-Cros M; deBeaumont RS; Delaunay C; Desplat A; Duong W; Dwoske DA; Eldridge RS; Farsidjani A; Feng F; Feng J; Flemming D; Forrester W; Galli GG; Gao Z; Gauter F; Gibaja V; Haas K; Hattenberger M; Hood T; Hurov KE; Jagani Z; Jenal M; Johnson JA; Jones MD; Kapoor A; Korn J; Liu J; Liu Q; Liu S; Liu Y; Loo AT; Macchi KJ; Martin T; McAllister G; Meyer A; Mollé S; Pagliarini RA; Phadke T; Repko B; Schouwey T; Shanahan F; Shen Q; Stamm C; Stephan C; Stucke VM; Tiedt R; Varadarajan M; Venkatesan K; Vitari AC; Wallroth M; Weiler J; Zhang J; Mickanin C; Myer VE; Porter JA; Lai A; Bitter H; Lees E; Keen N; Kauffmann A; Stegmeier F; Hofmann F; Schmelzle T; Sellers WR
    Cell; 2017 Jul; 170(3):577-592.e10. PubMed ID: 28753431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic sickness or lethality points at candidate combination therapy targets in glioblastoma.
    Szczurek E; Misra N; Vingron M
    Int J Cancer; 2013 Nov; 133(9):2123-32. PubMed ID: 23629686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of synthetic lethal interactions as cancer drug targets.
    Kuiken HJ; Beijersbergen RL
    Future Oncol; 2010 Nov; 6(11):1789-802. PubMed ID: 21142664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Interaction Motif Finding by expectation maximization--a novel statistical model for inferring gene modules from synthetic lethality.
    Qi Y; Ye P; Bader JS
    BMC Bioinformatics; 2005 Dec; 6():288. PubMed ID: 16332255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.
    Srivatsa S; Montazeri H; Bianco G; Coto-Llerena M; Marinucci M; Ng CKY; Piscuoglio S; Beerenwinkel N
    Nat Commun; 2022 Dec; 13(1):7748. PubMed ID: 36517508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.